Background An early psychotherapeutic treatment of anorexia nervosa (AN) is crucial for a good prognosis. In order to improve treatment initiation, knowledge about facilitators and barriers to treatment is needed. Objective Against this background, we aimed to identify facilitators and barriers from the perspectives of patients, carers and professionals using a qualitative approach. Method To this end, semi-structured interviews were conducted in triads of female patients with AN aged 14 years and older at the beginning of their first psychotherapeutic treatment, their carers, and referring health care professionals. A modified Grounded Theory approach was used for analysis. Results In total, 22 interviews were conducted (n = 6 adults, n = 4 adolescents, 4 full triads). The duration of untreated AN ranged between 30 days and 25.85 years (M = 3.06 ± 8.01 years). A wide spectrum of facilitators and barriers within the patient, the social environment, the health care system and the society were identified. Most prominent factors were ‘recognizing and addressing’ by close others, ‘waiting times and availability’ and ‘recommendations and referrals’ by health care professionals. ‘Positive role models for treatment’ were perceived as a specific facilitative social influence. Facilitators were more frequently mentioned than barriers and most of the factors seem to hold potential for modifiability. Conclusion Overall, the findings suggest that early intervention approaches for AN should not only address patients and the health care system, but may also involve carers and successfully treated former patients. Trial registration ClinicalTrials.gov Identifier: NCT03713541.
The authors developed a concept that applies self-organization theory to psychodynamic principles. According to this concept, episodes of temporary destabilization represent a precondition for abrupt changes within the therapeutic process. The authors examined six courses of therapy (patients diagnosed with depression and personality disorder). After each therapy session, patients rated their experience of the therapeutic interaction. A measure of instability was used to identify episodes of destabilization with respect to patients' interaction experience throughout the process. Episodes of pronounced destabilization occurred in the four courses of therapy that showed better therapy outcomes. These episodes were characterized by temporary strong deteriorations in interaction experience (negative peaks). Three of the four courses showed subsequent discontinuous improvements to a higher level of interaction. Results indicate that the systematic inclusion of a measure of instability is worthwhile in investigations of discontinuous changes. This method allows the theoretical assumptions of the psychodynamic approach to be tested.
BackgroundThe length of stay (LOS) strongly influences anorexia nervosa (AN) inpatient weight outcomes. Hence, understanding the predictors of LOS is highly relevant. However, the existing evidence is inconsistent and to draw conclusions, additional evidence is required.MethodsWe conducted a prospective, multi-center study including adult female inpatients with AN. Using stepwise linear regression, the following demographic and clinical variables were examined as potential predictors for LOS: admission BMI, AN-subtype, age, age of onset, living situation, partnership status, education, previous hospitalization, self-rated depression, anxiety and somatic symptoms (PHQ-9, PHQ-15, GAD-7), self-rated therapy motivation (FEVER) and eating disorder psychopathology (EDI-2 subscale scores).ResultsThe average LOS of the sample (n = 176) was 11.8 weeks (SD = 5.2). Longer LOS was associated with lower admission BMI (ß = −1.66; p < .001), purging AN-subtype (ß = 1.91; p = .013) and higher EDI-2 asceticism (ß = 0.12; p = .030). Furthermore, differences between treatment sites were evident.ConclusionsBMI at admission and AN-subtype are routinely assessed variables, which are robust and clinically meaningful predictors of LOS. Health care policies might consider these variables. In light of the differences between treatment sites future research on geographical variations in mental health care seems recommended.
Objective: We aimed to provide a comprehensive overview of the role of self-esteem in the treatment of patients with anorexia nervosa (AN). Specifically, our objectives were to investigate the differences in self-esteem between individuals with AN and healthy controls, or individuals with other eating disorders, and to examine self-esteem as an outcome, predictor, moderator, and mediator in AN treatment.Method: The databases PsycINFO, PSYNDEXplus, Ovid MEDLINE ® , and ProQuest were searched for studies published from 1990 to 2018. To estimate aggregated effect sizes, we performed random-effects meta-analyses.Results: A screening of 1,596 abstracts and 203 full-texts identified 68 relevant publications.Results suggest a significantly lower global self-esteem in individuals with AN than in healthy
Empirical research in this field necessitates clear operational definitions and the unambiguous use of related terms. We developed a classification system in order to systematize and operationalize different types of interventions. It can be used for process research and to summarize specific techniques used in psychotherapy training.
Background Anorexia nervosa is a serious disorder, which often takes a chronic course. Early treatment leads to a significantly better prognosis and prevents chronicity. However, existing evidence on facilitators and barriers in anorexia nervosa treatment initiation is scarce. Aims Against this background, the FABIANA study (ClinicalTrials.gov Identifier: NCT03713541) aims to (a) identify potentially modifiable facilitators and barriers from the perspectives of adolescent and adult patients with anorexia nervosa, carers and physicians, (b) develop and test an instrument for the combined assessment of multiple key facilitators and barriers, and (c) quantify the effect of potentially modifiable versus non-modifiable key facilitators and barriers on the duration of untreated illness (DUI) in patients with anorexia nervosa. Method FABIANA is an observational, mixed-method-study divided into three consecutive substudies each corresponding to one of the study aims. All three substudies will include female patients with anorexia nervosa aged 14 years and older at the beginning of their first psychotherapeutic anorexia nervosa treatment. The qualitative substudy I and the quantitative substudy III will additionally include carers and involved physicians. The recruitment will take place at 20 cooperating study centres throughout Germany, which provide in-patient or out-patient anorexia nervosa specialist care. The DUI will be calculated based on the month of illness onset as determined in validated interviews on lifetime anorexia nervosa symptoms and the therapist-reported date of treatment initiation. Conclusions Strengths and limitations of the retrospective assessment of the DUI will be discussed. The findings of the FABIANA study will contribute to the development of evidence-based early-intervention approaches and the prevention of a chronic course of illness. Trial registration ClinicalTrials.gov Identifier: NCT03713541. Declaration of interest None.
Zusammenfassung Theoretischer Hintergrund In Reaktion auf die durch die „coronavirus disease 2019“ (COVID-19) verursachte Pandemie konnte Psychotherapie im Einzelsetting in Deutschland unbegrenzt online durchgeführt werden. Haltungen und Erfahrungen von Psychotherapeuten (PT) bezüglich Onlinetherapie (OT) wurden jedoch allgemein und besonders mit Blick auf die Pandemiesituation bislang wenig untersucht. Ziel der Arbeit Ziele der Studie waren, 1) die Nutzungshäufigkeit von OT während des ersten Lockdowns, 2) die Zufriedenheit mit OT vs. „Face-to-face“-Therapie sowie 3) die Technologieakzeptanz und -erfahrung insgesamt und in Abhängigkeit vom Richtlinienverfahren zu untersuchen. Material und Methode Deutsche PT (approbiert und in Ausbildung; verhaltenstherapeutisch [VT, 45,6 %], tiefenpsychologisch [TP, 34,5 %], analytisch [AP, 14 %], systemisch [SYS, 5,8 %]) wurden mithilfe einer Onlineerhebung zu demografischen und therapeutischen Daten, durchgeführter OT, Zufriedenheit mit OT vs. Face-to-face-Therapie (Zufriedenheitsfragebogens für Therapeuten, ZUF-THERA) und Technologieakzeptanz (Unified Theory of Acceptance and Use of Technology 2 Questionnaire, UTAUT) befragt. Ergebnisse Die 174 teilnehmenden Therapeuten (Alter M = 44,73 Jahre, SD ± 12,79; 81,6 % Frauen) gaben an, dass der durchschnittliche Anteil von OT an der gesamten therapeutischen Tätigkeit während des Lockdowns 43,09 % betrug, wobei sich signifikante Unterschiede zwischen den Richtlinienverfahren zeigten (TP, VT > AP). Die Zufriedenheit mit OT erwies sich als signifikant niedriger als mit Face-to-face-Therapien und unterschied sich zwischen den Verfahren nicht. Vorerfahrungen mit OT hatten insgesamt 23,6 % der Therapeuten und vermehrt systemisch arbeitende im Vergleich zu VT- oder AP-Therapeuten. Verhaltenstherapeuten gaben häufiger an, Spaß an der OT zu haben, als TP- und APler. Auch nahmen sie einen stärkeren sozialen Einfluss (beispielsweise durch Kollegen) bei der Nutzung von OT wahr als die TPler. Schlussfolgerung Die Nutzungshäufigkeit von OT nahm während des ersten Lockdowns (März bis Mai 2020) sprunghaft zu (43 %, zum Vergleich das frühere Abrechnungslimit der Krankenkassen: 20 %). Die Zufriedenheit mit der OT war prinzipiell hoch, jedoch signifikant niedriger als mit Face-to-face-Therapien. Weiterführende Untersuchungen, die die Gründe im Detail analysieren, werden dringend angeraten.
Incentives should be systematically set to encourage services that are specific for treating chronic disorders. Systematic incentive for the improvement of the outpatient depression care should be given for example in particular for the achievements, which are important for the care of chronic disorders.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.